SPONSOR
Celltrion
Total Trials
2
Recruiting
2
Phases
Phase 3
NCT05906992 Phase 3
Recruiting
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
Relapsing-remitting Multiple Sclerosis
NCT07093476 Phase 3
Recruiting
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
T2DM